BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2020
View Archived Issues
Sudoku-solving algorithm predicts protein structure, too
Read More
Statins help pancreatic tumors go from bad to worse
Read More
Livin targeting: a promising immunotherapy for lymphomas resistant to Fas-mediated apoptosis
Read More
Annexon studies ANX-005 for Huntington's disease in phase II
Read More
Medicines for Malaria Venture begins phase I study of MMV-688533
Read More
FSD Pharma initiates phase II study of FSD-201 in hospitalized patients with COVID-19
Read More
ORIENT-32 study meets primary endpoints at interim analysis
Read More
Achelois Oncology describes CAR T cells expressing CD160
Read More
Cue Biopharma presents T-cell modulatory antigen-presenting polypeptides
Read More
New anti-CD47 antibodies disclosed by Beijing Guangwei Biotechnology
Read More
Quantum Genomics and collaborators present glutamyl aminopeptidase inhibitors
Read More
New sphingosine 1-phosphate receptor 1 ligands discovered at the University of Buea
Read More
Cerebral palsy risk has genetic component
Read More
FDA approves Fetroja for the treatment of HABP and VABP
Read More
FDA grants IND approval for phase II/III study of CardiolRx in patients with COVID-19
Read More
Ultomiris approved in Japan for aHUS in adults and children
Read More
Tecentriq and Avastin approved in Japan as first cancer immunotherapy for unresectable HCC
Read More
Phase I results reported for fusion protein tTF-NGR in advanced cancer patients
Read More
Enaroy approved in Japan for anemia associated with chronic kidney disease
Read More
First clinical data for AMG-160, a bispecific T-cell engager immunotherapeutic
Read More
Daewoong reports phase II data on enavogliflozin for type 2 diabetes
Read More
European Commission approves Heron's Zynrelef for postoperative pain
Read More
Sobrera and Recipharm collaborate on formulation development of SO-001 for alcohol use disorder
Read More
Primary endpoint not met with ipatasertib added to paclitaxel in HR+, HER2- breast cancer
Read More
Sarepta reports 2-year data with SRP-9001 gene therapy for DMD
Read More
FDA places partial clinical hold on planned phase II/III trial of INO-4800
Read More
Aligos receives CTA clearance to begin first-in-human study of ALG-000184 for hepatitis B
Read More